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Objective. To determine the efficacy of single-dose
benzathine penicillin G in infants at high risk of congenital
syphilis.
Design. Randomised study comparing benzathine
penicillin with no therapy.
Setting. Peninsula Maternal and Neonatal Service, Cape
Town.
Subjects. Asymptomatic infants born to mothers with
untreated syphilis whose VORl titre was 32 or more.
Outcome measures. The number of cases of congenital
syphilis was determined by results of IgM Western blots
and follow-up VDRL titres.
Results and conclusions. Of 8 patients followed up in
the non-treatment group. 4 had congenital syphilis while
Dill had the disease (P = 0.035) in the group receiving
benzathine penicillin. Although the exact failure rate is
unknown, benzathine penicillin is effective in preventing
symptomatic congenital syphilis when administered to
high-risk newboms.
S Afr Med J , 997; 87; 62-65.
The management of the asymptomatic newborn whose
mother has untreated or incompletely treated syphilis in
pregnancy remains an important paediatric problem. In
South Africa, 7 - 12% of women attending antenatal clinics
have positive serological tests for syphilis1-3 and therapy
during pregnancy is frequently inadequate or non-existent.3
Consequently large numbers of infants require evaluation
and management for potential congenital syphilis.
The optimal therapy for these apparently healthy infants,
however, is still being debated. In 1988, the Centers for
Disease Control (COG) modified existing guidelines so that
asymptomatic patients would receive a minimum of 10 days
of treatment with either procaine penicillin or aqueous
penicillin G." Until recently it was our policy at Groote
Schuur Hospital to follow the World Health Organisation
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recommendations for patients without evidence of
neurosyphilis, Le. well infants with normal cerebrospinal fluid
levels. Management included serial follow-up and monitoring
of serological tests or, when that was not possible, a single
dose of benzathine peniciJlin.s.6
Although benzathine penicillin has been widely used in
asymptomatic infants of mothers with syphilis, there have
been few definitive reports of its efficacy and, indeed,
isolated cases of treatment failure have been noted.'
We carried out a study in which infants at risk for
congenital syphilis were randomised to receive either a
single dose of benzathine penicillin or no therapy. We
determined outcome by means of clinical assessment and
serological testing (Venereal Disease Research Laboratory
(VDRL) and IgM Western blotting) at birth and follow-up.
Methods
Background
At the time of commencing the study, the hospital policy
was similar to that proposed by the WHO;6 i.e. patients with
clinical signs compatible with congenital syphilis were
treated, while apparently healthy infants were monitored and
serial VDRL titres were determined. Those with a fourfold
increase in titre or whose serum did not revert to negative by
6 months were regarded as infected and treated with
procaine penicillin 50 000 U/kg/day for 10 days.
It has not been our policy to perform routine lumbar
punctures on clinically healthy infants. Several studies have
indicated that the investigation is of little value in this group
of patients,B.g
We did not screen patients or mothers for HIV infection,
When the stUdy was carried out, the prevalence of the
disease was low among antenatal clinic attenders at the
Peninsula Maternal and Neonatal Service in the Western
Cape - approXimately 1:1 000 (A Keen - personal
communication).
Patient selection
We studied asymptomatic infants at high risk of congenital
syphilis. We regarded infants in this category as those born
to mothers with untreated syphilis, Le. positive VDRL and
treponema pallidum haemagglutination (TPHA) tests, with a
VDRL titre of 32 or more. to Infants were regarded as
asymptomatic at birth if: (I) there were no clinical signs of
congenital syphilis; (it) the radiographs of the long bones
were normal; and (;;1) the rheumatoid factor latex test was
negative at birth. l1
Mothers were interviewed soon after birth; only infants
who could be followed up were included in the study, which
commenced within 72 hours of birth. Infants were
randomised to receive either no treatment or a single
injection of benzathine penicillin 50 000 U/kg.
Follow-up was arranged at 6-weekly intervals after birth.
At these times the patients were examined clinically by one
of the authors (MR) and the VDRL test was repeated. If the
latter was negative at 3 months, the infant was discharged;
those with positive tests and declining titres were followed
up until the test became negative or features of congenital
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syphilis developed. Patients whose VDRL titre increased
fourfold or whose VDRL was still positive at 6 months were
regarded as having congenital syphilis and treated with
procaine penicillin 50 000 U/kg for 10 days.
Permission for the study was obtained from the Ethics
and Research Committee of the University of Cape Town
and informed consent was obtained from the mothers.
Western blotting
Serum collected at birth and follow-up visits was aliquoted,
frozen and stored at -aO°C. We performed batched testing
and the results were used to assist the diagnosis of
congenital syphilis. Whole serum was tested at birth, but
IgM fractions were used for the follow-up samples. The
latter procedure was followed because we noted f!. 10%
false-positive rate when whole serum was tested in older
infants outside the neonatal period.12 The false positives
were eliminated by testing of IgM fractions and were
presumably brought about by the presence of rheumatoid
factors (detected in 8.5% of healthy infants aged 1 - 4
months).13
The immunoblotting method has been described
elsewhere.12 A suspension of Treponema paJlidum antigens
was SUbjected to sodium dodecyl sulphate polyacrilamide
gel electrophoresis (SDS-PAGE) with a 12% separating gel.
Electrophoretic transfer of low molecular weight standards
(Biorad) and treponemal antigens to nitrocellulose paper was
then carried out. Strips were reacted with test serum at a
dilution of 1: 100 followed by a mu chain-specific anti-lgM
monoclonal antibody. The blots were developed with a
biotinylated rabbit anti-mouse antibody (Dako, Glostrup,
Denmark) and streptavidin-biotin horseradish peroxidase
complex (Dako). Substrate was diaminobenzene with cobalt
chloride and hydrogen peroxide.
IgM serum fractions were prepared using an ion exchange
column (Quick Sep, System 11; Isolab). The IgM
concentration in the eluate was determined and the blots
carried out at the same IgM level as was present in the
original sample.
We regarded IgM reactivity to treponemal antigens with
any of the following molecular weights as a positive blot: 72,
47,45,37,30,17 and 15 kDa."
Outcome and statistics
The diagnosis of congenital syphilis was based on a fourfold
rise in VDRL titre (and positive TPHA) during follow-up or a
persistently positive VDRL and TPHA after 6 months. In
addition, patients with a positive Western blot for IgM
antibody to T pallidum were regarded as having congenital
syphilis. 12
Patients who defaulted on follow-up in the non-treatment
group were assumed to be uninfected; this would have the
effect of reducing the apparent efficacy of treatment.
The initial study design was to enter 30 infants per group.
However, the presence of 4 congenitally infected infants in
the non-treatment group prompted an analysis of the data
after 22 patients had been enrolled; a significant difference
was found and the stUdy terminated.
Results
Altogether, 22 infants were studied. There were no
statistically significant differences between the two groups
with regard to birth weight (combined mean 2 941 9),
gestational age (combined mean 39.8 weeks), maternal
VDRL titre at delivery (median t28 in both groups) and infant
VDRL titre at birth (median 8 in both groups).
Non-treatment group
Of 10 patients enrolled, there were 4 with congenital
syphilis. In 3 cases the diagnosis was based on a fourfold
(or greater) rise in VDRL titre at follow-up. In addition, these
3 patients developed physical signs suggestive of congenital
syphilis at follow-up, having been completely asymptomatic
at birth (Table I). Western blots from these 3 patients had
IgM reactiVity to the 47dDa antigen (Fig. 1). Two had reactive
blots at birth (Fig. 1, lanes c and d) before any other
evidence of disease, either clinically or serologically. The
other patient demonstrated IgM reactivity (on both whole
serum and IgM fractions) by 10 weeks (Fig. 1, lanes e and fj.
The fourth patient with congenital syphilis had a strongly
positive Western blot for IgM at birth in the absence of
physical signs (Fig. 1, lane g).
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Clinical features at follow-up
Periosteal reaction
(at 12 wks)




Nil (at 24 wks)
Nil (at 12 wks)
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Fig. 1. Reaction profiles in Western blots. lane a - profile with
pooled IgG from T. pallidum-infected rabbit; lane b - IgM
reactivity in serum from control infant with symptomatic
congenital syphilis; lanes c and d - IgM profile at birth in 2
untreated, infected infants; lanes e and f - IgM reactivity at birth
and 3 months in an untreated, infected infant; lane 9 - IgM
pattern at birth in an untreated infant lost to follow-up.
There were 4 infants who were not infected. Their VDRL
titres had declined to zero by 4 months and they remained
healthy during this time. These infants had negative
immunoblots at birth and, in addition, showed no IgM
reactivity to the relevant treponemal antigens when column
fractions from the follow-up sera were tested.
In 2 cases follow-up was incomplete; in 1 case the VORL
titre had declined to 1 by 4 months and the infant (who
remained asymptomatic throughout) could not be traced for
repeat VORL The other patient died of diarrhoeal disease at
the age of 2 months; follow-up serology was not obtained.
Immunoblots from these 2 infants were negative. As
discussed above, for the purposes of analysis these 2 cases
were regarded as not infected.
Treatment group
.Twelve patients were enrolled in this group. Eleven were
followed up and the VORL titres declined to zero in the
absence of any signs of disease. The remaining infant died
of a congenital heart defect (hypoplastic left heart syndrome)
aged 2 weeks; there was no evidence of congenital infection
at postmortem. This case was excluded from the statistical
analysis.
Two of the 12 treated infants had an IgM response to the
47 kDa antigen at birth (Fig. 2, lanes c and fj. Following
treatment with a single dose of benzathine penicillin, the IgM
was no longer demonstrable in either patient by 3 months of
age (Fig. 2, lanes d, e and g). None of the remaining 10
patients had IgM reactivity with the relevant treponemal
antigens at birth or follow-up.
When the two groups were compared in respect of
outcome, there were significantly fewer cases of congenital
syphilis in the treatment group (0/11 compared with 4/10;
P = 0.035 (Fisher's exact test)). As a result of this, it was
decided to terminate the study.
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Fig. 2. Reactivity in Western blots. lane a - pooled IgG from T.
palJidum-infected rabbit; lane b - IgM profile with pooled serum
from adults with recent syphilis; lanes c, d and e - IgM reactivity
in sera from treated infant at birth, 3 months and 18 months;
lane~ f and 9 - IgM pattern obtained with sera from a treated
infant at birth and 3 months.
Discussion
Overall, the use of benzathine penicillin resulted in a
significant decline in the number of cases of congenital
syphilis in the high-risk group stUdied. There were no
treatment failures although the number of patients who were
indisputably infected was small. (Only 2 patients in the
treatment group had positive Western blots.) Once
benzathine penicillin had been demonstrated to have a
therapeutic effect the study was discontinued.
Of the 3 untreated infants who developed disease at
follow-up, 2 had positive Western blots at birth; this
sensitivity of 66% at birth was similar to that of 75%
reported in a previous study among infants with normal
long-bone radiographs." It should be noted that in the
present study all cases were IgM RF latex test negative at
birth.
We regarded the 2 newborns in the treatment group with
reactive blots as infected; we have not observed false-
positive blots at birth, either in the untreated infants in this
study who were followed up or among 21 neonates of
seropositive mothers described in a previous publication. '2
A single dose of benzathine penicillin appeared to have been
effective in these 2 patients as there was no clinical
development of disease and the Western blots had reverted
to negative by 3 months.
A recently pUblished study compared the efficacy of
benzathine penicillin with procaine penicillin in 152
newborns whose mothers had untreated or incompletely
treated syphilis during pregnancy. g There were no treatment
failures reported with either regimen. However, relatively few
infants were included whose mothers were untreated (8 in
the benzathine group and 11 recipients of procaine
penicillin). Altogether, 3 infants had positive FTA-ABS IgM
tests at birth and were therefore probably infected.'~
It is clear that reported experience with benzathine
penicillin in high-risk asymptomatic patients with congenital
syphilis is scarce. However, there have been few reports of
treatment failure over the years in spite of widespread use of
benzathine penicillin. The occurrence of disease following
therapy has been noted after use of both benzathine and
crystalline penicillin. T.I6.lT It is likely that treponemes in
environments such as the cerebrospinal fluid and aqueous
humour are able to persist because of poor penetration of
the antibiotic into these body compartments"a.19 The fact
that unsuccessful treatment with benzathine penicillin
appears to be rare may be related to the observation that
cerebrospinal fluid involvement in asymptomatic newborns
is uncommon.8.9
To determine the risk of late-onset disease after
benzathine penicillin treatment accurately requires the
evaluation of a relatively large cohort of high-risk patients.
This is important because the failure rate appears to be low
(possibly of the same order as that observed in adults with
primary or secondary syphilis, i.e. 3 - 5%).20 These data are
essential to determine whether the longer duration of
therapy, Le. the 10 - 14 days proposed by the COC (and
now recommended by the South African Department of
Health) is necessary.
In conclusion, the present study has confirmed that
benzathine penicillin G is effective in preventing
symptomatic congenital syphilis when administered to high-
risk newborns. The risk of treatment failure, however,
requires further evaluation.
We thank Or A E Baughn for providing strips for Western
blotting.
REFERENCES
1. Oelport so. Adhikari M. Van der Elst CW, Venter A. Congenital syphilis - a
neglected medical problem. S Afr Med .1 1989: 76: 287-288
2. Opai-Tetteh ET. Hoosen AA, Moodley J. Re-scre-ening for syphilis at the time of
delivery in areas of high prevalence. S Afr Med.l 1993; 83: 725-726
3 Swingler GH, Van Coeverden de Grool HA. The antenatal prevention of
congenital syphilis in a peri-urban settlement. S Afr Med .1 1993; 83: 34-35
4. Centers for Disease Control. Guid~ines for the prevention and control of syphilis.
MMWR 1988; 37: suppll, 1-13.
5. World Health Organization Expert Comminee on Venereal Disease and
Treponematoses. Sixth Report. WHO Tech Rep Ser 1986; 736: 126-129.
6. Kaufman RE, Jones OG, Blounl JH, Wiesner PJ. Ouestionnaire survey of reported
early congenital syphilis. Problems in diagnosis, prevention and treatment. Sex
Transm Ois 1977; 4,135-139.
7 Beck-Sague C. Alexander R. Failure of benzathine penicillin G treatment in early
congenital syphilis. Pediatr Infect Dis 1987; 6; 1061-1064.
8 Srinivasan G. Ramamurthy RS, Bharathi A, Voora S. Pildes RS. Congenital
syphilis: a diagnostic and Therapeutic dilemma. Pediatr Infect Dis 1983; 2: 436-
441.
9 Beeram M, Chopde N, Sriboe S. Abedin M. Lumbar puncture in the evaluation of
possible congenital syphilis in neonates. Pediarr Res 1994; 35: 293A.
10. Meyer MP, Malan AF. Risk factors for congenital syphilis. Ann Trop Paediatr 199t;
11: 193-198.
11. Meyer MP, Malan AF. Rheumatoid factor in congenital syphilis. Genitourin Med
1989; 65: 304·307.
12. Meyer MP, Eddy T, Baughn RE. Analysis of Western Blotting (Immunobloning)
technique in diagnosis of congenital syphilis. .l Clin Microbio/1994; 32.: 629-633.
13. Meyer MP. Congenital syphilis: the diagnostic value of the rheumatoid factor in
symptomatic patients. Ann Tmp Paediau 1993: 13: 369-372.
14. Paryani SG. Vaughn N, Crosby M. Lawrence S. Treatment of asymptomatic
congenital syphilis; benzathine versus procaine penicillin G therapy. .l Pediatr
1994; 125: 471-475
15. KaUfman RE. Olansky DC, Wiesner PJ. The FTA-ASS (lgM) tesl for neonatal
congenital syphilis: a critiCal review. .l Am Vener Dis Assoc 1974; 1: 79-84.
16. Hardy JB. Hardy PH, Oppenheimer EH. Ryan SJ, SheH RN. Failure of penleillin in
a neWborn with congenital syphilis. .lAMA 1970; 212: 1345-1349.
17. Woolf A, Wilfert C, Kelsey D. Gutman L. Childhood syphilis in North Carolina. N C
Med.l 1980; 41: 443-449.
18. Speer ME. Taber LH, ClarJ( DB, Rudolph AJ. Cerebrospinal fluid levels of
benzathine penicillin G in the neonate. .1 Pediatr 1977; 91: 996-999.
19. Ryan SJ, Hardy PH, Hardy JM, Oppenheimer EH. Persistence of virulent
Treponema pa/lidum despite penicillin therapy in congenital syphilis. Am .l
aphtha/mol 1972; 73: 258-261.
20. Schroeter AL, Lucas JB. Price 81, Falcone VH. Treatment for early syphilis and
reactivity of serologic tests. .lAMA 1972; 221: 471-476.









L Dudley, G Hussey, J Huskissen, G Kessow
Objective. This study evaluated the association between
vitamin A status and the severity of acute respiratory
infections (AAIs) in children, controlling for the influence of
other known AAI risk factors.
Design. Case control study_
Setting. Ambulatory and hospital-based stUdy.
Patients. Severe cases (N = 35) were children with AAI
who were admitted to hospital for inpatient treatment,
while mild cases (N = 32) were children with AAI who were
treated as outpatients. The control group (N = 54) was
selected from children with non-infectious diseases
attending the outpatient department. Cases and controls
were matched for age and area of residence.
Main outcome measures. Serum vitamin A levels and
analysis of ARI risk factors.
Results. The mean (SD) vitamin A levels were 22.09 (7.27)
~g/dl for the controls, 20.27 (11.11) ~g/dl forthe mild cases
and 13.79 (7.60) ~g/dl for the severe cases. All pairwise
comparisons of levels of the three patient groups achieved
statistical' significance - severe and mild (P < 0.01), severe
and control (P < 0.001) and mild and control (P =0.03). After
vitamin A levels were dichotomised, the odds ratios (and
95% confidence intervals) for severe versus mild cases
were 2.1 (0.8 - 5.6), for mild versus controls 2.9 (0.8 - 10.5)
and for severe versus controls 6.0 (2.0 - 19.4). A t for trend
across the three groups was 13.2 (P =0.001). Risk factors
significantly associated with disease status included a
history of hospital admission in the preceding 6 months,
absence of a clinic card, poor housing and lack of
electricity for indoor fuel use. Factors associated with poor
vitamin A status included low weight for age, previous
diarrhoeal disease and poor housing. Vitamin A status was
independently associated with disease status in logistic
regression modelling.
Conclusion. Vitamin A status has a strong association
with severity of infection. The gradient of that association
suggests a dose-response effect. The multifactorial nature
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